RT Journal Article
SR Electronic
T1 COVID-19 Vaccination Mandates and Vaccine Uptake
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.21.21265355
DO 10.1101/2021.10.21.21265355
A1 Karaivanov, Alexander
A1 Kim, Dongwoo
A1 Lu, Shih En
A1 Shigeoka, Hitoshi
YR 2021
UL http://medrxiv.org/content/early/2021/10/25/2021.10.21.21265355.abstract
AB We estimate the impact of government-mandated proof of vaccination requirements for access to public venues and non-essential businesses on COVID-19 vaccine uptake. We use event-study and difference-in-differences approaches exploiting the variation in the timing of these measures across Canadian provinces. We find that the announcement of a vaccination mandate is associated with large increase in new first-dose vaccinations in the first week (more than 50% on average) and the second week (more than 100%) immediately following the announcement. The estimated effect starts waning about six weeks past the announcement. Counterfactual simulations using our estimates suggest that these mandates have led to about 289,000 additional first-dose vaccinations in Canada as of September 30, 2021, which is 1 to 8 weeks after the policy announcements across the different provinces. Time-series analysis corroborates our results for Canada, and we further estimate that national vaccine mandates in three European countries also led to large gains in first-dose vaccinations (7+ mln in France, 4+ mln in Italy and 1+ mln in Germany, 7 to 12 weeks after the policy announcements). NOTE: The reported numbers may change with more data. Please see updated version when available.Note on data availability The proof of vaccination mandates that we analyze in this paper are recent policies, as several Canadian provinces announced the mandates not long before the current sample end date September 30, 2021. As more data become available and we include them in our analysis, our estimate of the average effect of a mandate announcement on vaccine uptake may change. For example, to the extent that the large increase in first dose vaccinations we observe may include intertemporal substitution (people receiving the vaccine sooner than otherwise intended), the estimated net gain in vaccinations (people who otherwise would not have become immunized), relative to the no-mandate counterfactual, could be overstated. On the other hand, we expect our estimates for the initial increase in first doses (the first two weeks after the announcement) not to be affected much by the additional data. Lastly, many of the announced mandates are coming into force at the time of writing, which could provide an additional increase in vaccinations that we intend to analyze.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding external to the authors' home institution was received for this project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data used in this manuscript is based on information available in public domain. Data sources and links are provided within the manuscript.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this manuscript is based on information available in public domain. Data sources and links are provided within the manuscript.